11+ hour, 40+ min ago  (469+ words) Plataforma Media NOROO Holdings Advances Commercialization of Bio-Based 3-HP Through Major Korean Government Initiative - Selected as the lead organization for a major government-backed initiative to accelerate commercialization of bio-based 3-HP through pilot-scale investments. - Establishing an integrated R&D value chain…...

3+ hour, 4+ min ago  (488+ words) Bio Pharma APAC - Xtal Pi Lands $400 M+ AI-Driven Drug Discovery Partnership for Metabolic GPCR Target 11 June 2026 | Thursday | News Xtal Pi (2228. HK), a leading platform in artificial intelligence (AI) and robotics-driven drug discovery, announced a strategic partnership with a prominent international…...

9+ hour, 24+ min ago  (488+ words) Traditional neuroscience screens rely on mice and immortalized cell lines. In contrast, Verge Labs capitalizes on direct human data to capture disease complexity. Consequently, its scientists argue that targets selected from patient tissue will translate better into clinics. That claim…...

9+ hour, 43+ min ago  (272+ words) Posted by: Georg D'rendinger Despite being a highly innovative country, with a proud history of pharmaceutical industry-driven economic strength, and high purchasing power, Switzerland has neglected the opportunity to keep its healthcare system prepared for the wave of breakthrough therapies…...

2+ hour, 55+ min ago  (24+ words) Law360 Protecting AI-Driven Innovation In Life Sciences IP To view the full article, register now....

2+ hour, 4+ min ago  (13+ words) First Word Pharma...

2+ hour, 20+ min ago  (517+ words) The National Law Review Big Hat Biosciences Appoints Stefan Weigand as Chief Scientific Officer Veteran biologics leader brings more than 25 years of drug discovery experience and a track record of pipeline-scale impact at Roche SAN MATEO, Calif. --(BUSINESS WIRE)--Big…...

7+ hour, 31+ min ago  (395+ words) Optimi Health has exported psilocybin products to the UK for a Phase 2 clinical trial, utilizing its GMP facility. Optimi's export supports a planned Phase 2 clinical trial in the UK, marking a significant step in their research efforts. Optimi's products are…...

8+ hour, 33+ min ago  (486+ words) Bio Space Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines The collaboration will leverage Orionis's advanced Allo'Glue" platform and its AI'driven discovery engine BOSTON & GHENT, Belgium--(BUSINESS WIRE)--Orionis Biosciences, a privately held, clinical-stage…...

6+ hour, 38+ min ago  (133+ words) Pharma Dispatch ARCS evolves into Life Sciences Australia as part of wider strategic change ARCS has announced it is now Life Sciences Australia, with the name change part of a strategic push to better support professionals across the expanding life…...